|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weiss SA, Hanniford D, Hernando E and
Osman I: Revisiting determinants of prognosis in cutaneous
melanoma. Cancer. 121:4108–4123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zainulabadeen A, Yao P and Zare H:
Underexpression of specific interferon genes is associated with
poor prognosis of melanoma. PLoS One. 12:e01700252017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tiffen J, Wilson S, Gallagher SJ, Hersey P
and Filipp FV: Somatic copy number amplification and
hyperactivating somatic mutations of EZH2 correlate with DNA
methylation and drive epigenetic silencing of genes involved in
tumor suppression and immune responses in melanoma. Neoplasia.
18:121–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim BH, Shenoy AR, Kumar P, Bradfield CJ
and MacMicking JD: IFN-inducible GTPases in host cell defense. Cell
Host Microbe. 12:432–444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hotter D, Sauter D and Kirchhoff F:
Guanylate binding protein 5: Impairing virion infectivity by
targeting retroviral envelope glycoproteins. Small GTPases.
8:31–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goo YH, Son SH, Yechoor VK and Paul A:
Transcriptional profiling of foam cells reveals induction of
guanylate-binding proteins following western diet acceleration of
atherosclerosis in the absence of global changes in inflammation. J
Am Heart Assoc. 5:e0026632016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tripal P, Bauer M, Naschberger E,
Mörtinger T, Hohenadl C, Cornali E, Thurau M and Stürzl M: Unique
features of different members of the human guanylate-binding
protein family. J Interferon Cytokine Res. 27:44–52. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Degrandi D, Konermann C, Beuter-Gunia C,
Kresse A, Würthner J, Kurig S, Beer S and Pfeffer K: Extensive
characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in
host defense. J Immunol. 179:7729–7740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vestal DJ and Jeyaratnam JA: The
guanylate-binding proteins: Emerging insights into the biochemical
properties and functions of this family of large interferon-induced
guanosine triphosphatase. J Interferon Cytokine Res. 31:89–97.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shenoy AR, Wellington DA, Kumar P, Kassa
H, Booth CJ, Cresswell P and MacMicking JD: GBP5 promotes NLRP3
inflammasome assembly and immunity in mammals. Science.
336:481–485. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friedman K, Brodsky AS, Lu S, Wood S, Gill
AJ, Lombardo K, Yang D and Resnick MB: Medullary carcinoma of the
colon: A distinct morphology reveals a distinctive immunoregulatory
microenvironment. Mod Pathol. 29:528–541. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Britzen-Laurent N, Lipnik K, Ocker M,
Naschberger E, Schellerer VS, Croner RS, Vieth M, Waldner M,
Steinberg P, Hohenadl C and Stürzl M: GBP-1 acts as a tumor
suppressor in colorectal cancer cells. Carcinogenesis. 34:153–162.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Britzen-Laurent N, Herrmann C, Naschberger
E, Croner RS and Stürzl M: Pathophysiological role of
guanylate-binding proteins in gastrointestinal diseases. World J
Gastroenterol. 22:6434–6443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naschberger E, Croner RS, Merkel S,
Dimmler A, Tripal P, Amann KU, Kremmer E, Brueckl WM, Papadopoulos
T, Hohenadl C, et al: Angiostatic immune reaction in colorectal
carcinoma: Impact on survival and perspectives for antiangiogenic
therapy. Int J Cancer. 123:2120–2129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Godoy P, Cadenas C, Hellwig B, Marchan R,
Stewart J, Reif R, Lohr M, Gehrmann M, Rahnenführer J, Schmidt M
and Hengstler JG: Interferon-inducible guanylate binding protein
(GBP2) is associated with better prognosis in breast cancer and
indicates an efficient T cell response. Breast Cancer. 21:491–499.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lipnik K, Naschberger E, Gonin-Laurent N,
Kodajova P, Petznek H, Rungaldier S, Astigiano S, Ferrini S, Stürzl
M and Hohenadl C: Interferon gamma-induced human guanylate binding
protein 1 inhibits mammary tumor growth in mice. Mol Med.
16:177–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu CJ, Chang KP, Chang YJ, Hsu CW, Liang
Y, Yu JS, Chi LM, Chang YS and Wu CC: Identification of
guanylate-binding protein 1 as a potential oral cancer marker
involved in cell invasion using omics-based analysis. J Proteome
Res. 10:3778–3788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guimarães DP, Oliveira IM, de Moraes E,
Paiva GR, Souza DM, Barnas C, Olmedo DB, Pinto CE, Faria PA, De
Moura Gallo CV, et al: Interferon-inducible guanylate binding
protein (GBP)-2: A novel p53-regulated tumor marker in esophageal
squamous cell carcinomas. Int J Cancer. 124:272–279. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fellenberg F, Hartmann TB, Dummer R,
Usener D, Schadendorf D and Eichmüller S: GBP-5 splicing variants:
New guanylate-binding proteins with tumor-associated expression and
antigenicity. J Invest Dermatol. 122:1510–1517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Persano L, Moserle L, Esposito G, Bronte
V, Barbieri V, Iafrate M, Gardiman MP, Larghero P, Pfeffer U,
Naschberger E, et al: Interferon-alpha counteracts the angiogenic
switch and reduces tumor cell proliferation in a spontaneous model
of prostatic cancer. Carcinogenesis. 30:851–860. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lubeseder-Martellato C, Guenzi E, Jörg A,
Töpolt K, Naschberger E, Kremmer E, Zietz C, Tschachler E, Hutzler
P, Schwemmle M, et al: Guanylate-binding protein-1 expression is
selectively induced by inflammatory cytokines and is an activation
marker of endothelial cells during inflammatory diseases. Am J
Pathol. 161:1749–1759. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guenzi E, Töpolt K, Cornali E,
Lubeseder-Martellato C, Jörg A, Matzen K, Zietz C, Kremmer E, Nappi
F, Schwemmle M, et al: The helical domain of GBP-1 mediates the
inhibition of endothelial cell proliferation by inflammatory
cytokines. EMBO J. 20:5568–5577. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng YS, Colonno RJ and Yin FH:
Interferon induction of fibroblast proteins with guanylate binding
activity. J Biol Chem. 258:7746–7750. 1983.PubMed/NCBI
|
|
27
|
Anaya J: OncoLnc: Linking TCGA survival
data to mRNAs, miRNAs, and lncRNAs. Peer J Comput Sci. 2:e672016.
View Article : Google Scholar
|
|
28
|
Shaul YD, Yuan B, Thiru P, Nutter-Upham A,
McCallum S, Lanzkron C, Bell GW and Sabatini DM: MERAV: A tool for
comparing gene expression across human tissues and cell types.
Nucleic Acids Res. 44:D560–D566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carithers LJ, Ardlie K, Barcus M, Branton
PA, Britton A, Buia SA, Compton CC, DeLuca DS, Peter-Demchok J,
Gelfand ET, et al: A novel approach to high-quality postmortem
tissue procurement: The GTEx project. Biopreserv Biobank.
13:311–319. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:(Web Server Issue). W214–W220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Olszewski MA, Gray J and Vestal DJ: In
silico genomic analysis of the human and murine guanylate-binding
protein (GBP) gene clusters. J Interferon Cytokine Res. 26:328–352.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Britzen-Laurent N, Bauer M, Berton V,
Fischer N, Syguda A, Reipschläger S, Naschberger E, Herrmann C and
Stürzl M: Intracellular trafficking of guanylate-binding proteins
is regulated by heterodimerization in a hierarchical manner. PLoS
One. 5:e142462010. View Article : Google Scholar : PubMed/NCBI
|
